Page 213 - Full Book_24.4.2021

NOTES TO THE
FINANCIAL STATEMENTS in retrospect

|
for the financial year ended 31 december 2020 (continUed)
the Will to Suceed

|
2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
2.27 Employee benefits (continued)
Share-based payment transactions achieving a leading repute
the grant date fair value of share-based payment granted to employees is recognised as an employee expense, with a
corresponding increase in equity, over the period that the employees unconditionally become entitled to the awards. |
the amount recognised as an expense is adjusted to reflect the number of awards for which the related service and
non-market vesting conditions are expected to be met, such that the amount ultimately recognised as an expense is based
on the number of awards that meet the related service and non-market performance conditions at the vesting date.
for share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is Paving the Way for a Sustainable future
measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.
the fair value of the employee share options is measured using monte carlo Simulation. measurement inputs include
share price on measurement date, exercise price of the instrument, expected volatility (based on weighted average historic
volatility adjusted for changes expected due to publicly available information), expected dividends, and the risk-free profit
rate (based on government bonds). Service and non-market performance conditions attached to the transactions are not
taken into account in determining fair value. 207

2.28 Earnings per ordinary share
the Group presents basic earnings per share data for its ordinary shares (“ePS”).
basic ePS is calculated by dividing the profit or loss attributable to ordinary shareholders of the company by the weighted
average number of ordinary shares outstanding during the period, adjusted for own shares held.
diluted ePS is determined by adjusting the profit or loss attributable to ordinary shareholders and the weighted average adhering to the best Governance Practices
number of ordinary shares outstanding, adjusted for own shares held, for the effects of all dilutive potential ordinary
shares, which comprise share options granted to employees.

2.29 Fair value measurements |
‘fair value’ is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date in the principal or, in its absence, the most advantageous market
to which the Group has access at that date. the fair value of a liability reflects its non-performance risk.
When available, the Group measures the fair value of an instrument using the quoted price in an active market for that Laying the Foundation for Financial Growth
instrument. a market is regarded as active if transactions for the asset or liability take place with sufficient frequency and
volume to provide pricing information on an ongoing basis.

if there is no quoted price in an active market, then the Group uses valuation techniques that maximise the use of relevant
observable inputs and minimise the use of unobservable inputs. the chosen valuation technique incorporates all of the
|
factors that market participants would take into account in pricing a transaction.
the best evidence of the fair value of a financial instrument at initial recognition is normally the transaction price –
i.e. the fair value of the consideration given or received. if the Group determines that the fair value at initial recognition
differs from the transaction price and the fair value is evidenced neither by a quoted price in an active market for an
identical asset or liability nor based on a valuation technique that uses only data from observable markets, then the additional information & disclosure Summary
financial instrument is initially measured at fair value, adjusted to defer the difference between the fair value at initial
recognition and the transaction price. Subsequently, that difference is recognised in profit or loss on an appropriate basis
over the life of the instrument but no later than when the valuation is wholly supported by observable market data or
the transaction is closed out. |
24 th aGm information